• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; STENT, ILIAC Back to Search Results
Catalog Number BXA065902E
Device Problem Obstruction of Flow (2423)
Patient Problems Renal Failure (2041); Hypovolemia (2243); Blood Loss (2597)
Event Date 08/01/2019
Event Type  Injury  
Manufacturer Narrative
The device remains implanted in the patient.The device remains implanted in the patient.The delivery system was not returned for investigation.The device remains implanted in the patient.Results pending completion of review of manufacturing records.
 
Event Description
According to the database entries of the study the patient presented with a thoracoabdominal aneurysm iv.On (b)(6) 2019, during endovascular intervention, the aortic aneurysm was treated with an unknown fenestrated / branched stent graft component.Access was gained by axillary cut-down.For visceral perfusion a gore® viabahn® vbx balloon expandable endoprosthesis was implanted in the superior mesenteric artery, the left renal artery and the right renal artery.The viabahn® vbx devices were navigated to their intended location and deployed without issues.At the end of the procedure all viabahn® vbx devices were patent.During the procedure an estimated blood loos of 800 ml occurred.One blood transfusion was needed after the surgery and one more the next day.On (b)(6) 2019, a planned routine follow-up control computed tomography was performed.It was reported that imaging showed that the viabahn® vbx device implanted in the right renal artery was thrombosed and that the right kidney had already atrophy.The patient is asymptomatic, therefore the date of the occlusion of the renal artery remains unknown.It was stated, that this is a permanent fact, the kidney cannot be re-perfused, there is no therapy available.Thus, permanent impairment of body structure or function was noted.
 
Manufacturer Narrative
B5: updated event description: removal of language "according to the database entries of the study".H6-code 3331: the investigation involved the analysis of relevant production records in view of supporting the identification of possible causes for the adverse event.H6-code 213: a review of the manufacturing records indicated the device met pre-release specifications.H6-code 3221: the device was not returned for investigation.It remains implanted in the patient.Review and analysis of all available information fails to indicate a potential root cause of the incident as reported to gore.
 
Event Description
The patient presented with a thoracoabdominal aneurysm iv.On (b)(6), 2019, during endovascular intervention, the aortic aneurysm was treated with an unknown fenestrated / branched stent graft component.Access was gained by axillary cut-down.For visceral perfusion a gore® viabahn® vbx balloon expandable endoprosthesis was implanted in the superior mesenteric artery, the left renal artery and the right renal artery.The viabahn® vbx devices were navigated to their intended location and deployed without issues.At the end of the procedure all viabahn® vbx devices were patent.During the procedure an estimated blood loos of 800 ml occurred.One blood transfusion was needed after the surgery and one more the next day.On (b)(6), 2019, a planned routine follow-up control computed tomography was performed.It was reported that imaging showed that the viabahn® vbx device implanted in the right renal artery was thrombosed and that the right kidney had already atrophy.The patient is asymptomatic, therefore the date of the occlusion of the renal artery remains unknown.It was stated, that this is a permanent fact, the kidney cannot be re-perfused, there is no therapy available.Thus, permanent impairment of body structure or function was noted.
 
Manufacturer Narrative
H6-code 4315: the investigation findings did not lead to a clear conclusion about the cause of the reported adverse event.
 
Manufacturer Narrative
Previously reported h6-code 2597 and h6-code 2243 are no longer applicable.The issue is processed with mfr report #2017233-2019-00925, gore event (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
STENT, ILIAC
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9121991
MDR Text Key160125953
Report Number2017233-2019-00924
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Type of Report Initial,Followup,Followup,Followup
Report Date 11/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/26/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/19/2021
Device Catalogue NumberBXA065902E
Device Lot Number18420185
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Disability;
Patient Age78 YR
Patient Weight81
-
-